Mapping the human toxome by systems toxicology

Basic and Clinical Pharmacology and Toxicology

Volumn 115, Issue 1, 2014, Pages 24-31

  Bouhifd, Mounir ^a   Hogberg, Helena T ^a   Kleensang, Andre ^a   Maertens, Alexandra ^a   Zhao, Liang ^a   Hartung, Thomas ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; CATHEPSIN D; CRESOL; DIETHYLSTILBESTROL; ENDOCRINE DISRUPTOR; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN RELATED RECEPTOR ALPHA; ESTROGEN RELATED RECEPTOR BETA; ESTROGEN RELATED RECEPTOR GAMMA; G PROTEIN COUPLED RECEPTOR 30; GENISTEIN; NONYLPHENOL; PROGESTERONE RECEPTOR; PROGESTERONE RECEPTOR PS2; TAMOXIFEN; TESTOSTERONE; UNCLASSIFIED DRUG;

ARTICLE; BIOINFORMATICS; COMPUTER PROGRAM; GENE EXPRESSION PROFILING; GENETIC TOXICOLOGY; HUMAN; IN VITRO STUDY; INFORMATION PROCESSING; MCF 7 CELL LINE; METABOLOMICS; MICROARRAY ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REFERENCE DATABASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; TOXICITY TESTING; TRANSCRIPTOMICS; VALIDATION PROCESS; ANIMAL; ANIMAL MODEL; PROCEDURES; REPRODUCIBILITY; TOXICITY;

ANIMALIA;

ANIMALS; ENDOCRINE DISRUPTORS; GENE EXPRESSION PROFILING; HUMANS; METABOLOMICS; MODELS, ANIMAL; REPRODUCIBILITY OF RESULTS; SOFTWARE; TOXICITY TESTS;

EID: 84902073326     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/bcpt.12198     Document Type: Article

References (53)

1. European Commission. Report on the operation of directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances. Directive 88/379/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous preparations. Regulation (EEC) 793/93 on the evaluation and control of the risks of existing substances. Directive 76/769/EEC on the approximation of the laws, regulations, and administrative provisions of the Member States relating to restrictions on the marketing and use of certain dangerous substances and preparations. Commission working document. SEC (98) 1986 final. 18 November 1998.
2. Roe D, Pease W, Florini K, Silbergeld E. Toxic Ignorance: The Continuing Absence of Basic Health Testing for Top-Selling Chemicals in the United States. Environmental Defense Fund, New York, 1997;65.
3. NRC Committee on toxicity testing and assessment of environmental agents. Toxicity Testing in the 21st Century: A Vision and a Strategy. The National Academies Press, Washington, DC, 2007.
4. Hartung T. Toxicology for the twenty-first century. Nature 2009;460:208-12.
5. Bottini AA, Hartung T. Food for Thought... on the economics of animal testing. ALTEX 2009;26:3-16.
6. Leist M, Hartung T. Inflammatory findings on species extrapolations: humans are definitely no 70-kg mice. Arch Toxicol 2013;87:563-7.
7. Hartung T. Food for thought... on alternative methods for chemical safety testing. ALTEX 2010;27:3-14.
8. Hartung T. A toxicology for the 21st century-mapping the road ahead. Toxicol Sci 2009;109:18-23.
9. Basketter DA, Clewell H, Kimber I, Rossi A, Blaauboer B, Burrier R et al. A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing - t4 report*. ALTEX 2012;29:3-91.
10. Hartung T, McBride M. Food for Thought... on mapping the human toxome. ALTEX 2011;28:83-93.
11. Hartung T. Lessons learned from alternative methods and their validation for a new toxicology in the 21st century. J Toxicol Environ Health B Crit Rev 2010;13:277-90.
12. Hartung T. From alternative methods to a new toxicology. Eur J Pharm Biopharm 2011;77:338-49.
13. Hartung T, van Vliet E, Jaworska J, Bonilla L, Skinner N, Thomas R. Systems toxicology. ALTEX 2012;29:119-28.
14. Juberg D, Borghoff S, Becker R, Casey W, Hartung T, Holsapple M et al. t4 Workshop Report: Lessons Learned, Challenges, and Opportunities: The US Endocrine Disruptor Screening Program. Altex [Internet]. 2013. Available from: http://www.altex.ch/resources/WR_Juberg_epub.pdf.
15. ICCVAM/NICEATM. Expert Panel Evaluation of the Validation Status of In Vitro Test Methods for Detecting Endocrine Disruptors: Estrogen Receptor and Androgen Receptor Binding and Transcriptional Activation Assays, 2003. Available from: http://iccvam.niehs.nih.gov/docs/endo_docs/expertpanfinalrpt/panelrpt1102.pdf.
16. Wilson VS, Bobseine K, Gray LE. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists. Toxicol Sci 2004;81:69-77.
17. Naciff JM, Daston GP. Toxicogenomic approach to endocrine disrupters: identification of a transcript profile characteristic of chemicals with estrogenic activity. Toxicol Pathol 2004;32(Suppl. 2):59-70.
18. Robertson DG. Metabonomics in toxicology: a review. Toxicol Sci 2005;85:809-22.
19. Bouhifd M, Hartung T, Hogberg HT, Kleensang A, Zhao L. Review: toxicometabolomics. J Appl Toxicol 2013;33:1365-83.
20. Ramirez T, Daneshian M, Kamp H, Bois FY, Clench MR, Coen M et al. Metabolomics in toxicology and preclinical research. ALTEX 2013;30:209-25.
21. van Vliet E, Morath S, Eskes C, Linge J, Rappsilber J, Honegger P et al. A novel in vitro metabolomics approach for neurotoxicity testing, proof of principle for methyl mercury chloride and caffeine. Neurotoxicology 2008;29:1-12.
22. Reif DM, Martin MT, Tan SW, Houck KA, Judson RS, Richard AM et al. Endocrine profiling and prioritization of environmental chemicals using toxcast data. Environ Health Persp 2010;118:1714-20.
23. Liang S, Fuhrmann S, Somoyi R. A general reverse engineering algorithm for interference of genetic network architectures. Pac Symp Biocomput 1998;3:18-29.
24. Butte AJ, Kohane IS. Unsupervised knowledge discovery in medical databases using relevance networks. Proc AMIA Symp 1999;711-5.
25. D'haeseleer P, Wen X, Fuhrman S, Somogyi R. Mining the gene expression matrix: inferring gene relationships from large scale gene expression data. In: Holcombe M, Paton R (eds). Information Processing in Cells and Tissues. Springer US, New York; 1998;203-12.
26. Alon U. An Introduction to Systems Biology: Design Principles of Biological Circuits. CRC press, Boca Raton, FL, 2007.
27. Alon U. Network motifs: theory and experimental approaches. Nat Rev Genet 2007;8:450-61.
28. Alon U. Simplicity in biology. Nature 2007;446:497.
29. Cho CR, Labow M, Reinhardt M, van Oostrum J, Peitsch MC. The application of systems biology to drug discovery. Curr Opin Chem Biol 2006;10:294-302.
30. Fischer HP. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery. Biotechnol Ann Rev 2005;11:1-68.
31. Kwoh CK, Ng PY. Network analysis approach for biology. CMLS 2007;64:1739-51.
32. Sieberts SK, Schadt EE. Moving toward a system genetics view of disease. Mamm Genome 2007;18:389-401.
33. Aldridge BB, Burke JM, Lauffenburger DA, Sorger PK. Physicochemical modelling of cell signalling pathways. Nat Cell Biol 2006;8:1195-203.
34. Kleensang A, Maertens A, Rosenberg M, Fitzpatrick S, Lamb J, Auerbach S et al. t4 workshop report: pathways of toxicity. Altex 2014;31:53-61.
35. Blaauboer BJ, Boekelheide K, Clewell HJ, Daneshian M, Dingemans MML, Goldberg AM et al. The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans. ALTEX 2012;29:411-25.
36. Hartung T, Luechtefeld T, Maertens A, Kleensang A. Integrated testing strategies for safety assessments. ALTEX 2013;30:3-18.
37. Leist M, Hasiwa N, Daneshian M, Hartung T. Validation and quality control of replacement alternatives - current status and future challenges. Toxicol Res UK 2012;1:8-22.
38. Hartung T. Evidence-based toxicology - the toolbox of validation for the 21st century? ALTEX 2010;27:253-63.
39. Hartung T. Food for Thought... on evidence-based toxicology. ALTEX 2009;26:75-82.
40. Chang WC, Li CW, Chen BS. Quantitative inference of dynamic regulatory pathways via microarray data. BMC Bioinformatics 2005;6:44.
41. Haverty PM, Hansen U, Weng Z. Computational inference of transcriptional regulatory networks from expression profiling and transcription factor binding site identification. Nucleic Acids Res 2004;32:179-88.
42. Wang YC, Chen BS. Integrated cellular network of transcription regulations and protein-protein interactions. BMC Syst Biol 2010;4:20.
43. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997;138:863-70.
44. Tsai CL, Wu HM, Lin CY, Lin YJ, Chao A, Wang TH et al. Estradiol and tamoxifen induce cell migration through GPR30 and activation of focal adhesion kinase (FAK) in endometrial cancers with low or without nuclear estrogen receptor a (ER alpha). PLoS One 2013;8:e72999.
45. Takayanagi S, Tokunaga T, Liu XH, Okada H, Matsushima A, Shimohigashi Y. Endocrine disruptor bisphenol A strongly binds to human estrogen-related receptor gamma (ERR gamma) with high constitutive activity. Toxicol Lett 2006;167:95-105.
46. Dong S, Terasaka S, Kiyama R. Bisphenol A induces a rapid activation of Erk1/2 through GPR30 in human breast cancer cells. Environ Pollut 2011;159:212-8.
47. Rogers JA, Metz L, Yong VW. Review: endocrine disrupting chemicals and immune responses: a focus on bisphenol-A and its potential mechanisms. Mol Immunol 2013;53:421-30.
48. Mclachlan JA, Newbold RR. Estrogens and Development. Environ Health Persp 1987;75:25-7.
49. Barkhem T, Carlsson B, Nilsson Y, Enmark E, Gustafsson JA, Nilsson S. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. Mol Pharmacol 1998;54:105-12.
50. Bonefeld-Jorgensen EC, Long M, Hofmeister MV, Vinggaard AM. Endocrine-disrupting potential of bisphenol A, bisphenol A dimethacrylate, 4-n-nonylphenol, and 4-n-octylphenol in vitro: new data and a brief review. Environ Health Perspect 2007;115(Suppl. 1):69-76.
51. White R, Jobling S, Hoare SA, Sumpter JP, Parker MG. Environmentally persistent alkylphenolic compounds are estrogenic. Endocrinology 1994;135:175-82.
52. Soto AM, Justicia H, Wray JW, Sonnenschein C. p-Nonyl-phenol: an estrogenic xenobiotic released from "modified" polystyrene. Environ Health Perspect 1991;92:167-73.
53. Wada H, Tarumi H, Imazato S, Narimatsu M, Ebisu S. In vitro estrogenicity of resin composites. J Dent Res 2004;83:222-6.